CAS 1353485-38-7

Enoblituzumab

CAS: 1353485-38-7

Enoblituzumab is a humanized IgG1 κmab monoclonal antibody that recognizes human B7-H3 protein and can be used to study solid tumors such as non-small cell lung

Reinheit: 95% - 96.7% (SDS-PAGE); 98.5% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 145.81 kDa

Ref: TM-T9901A-002

Enoblituzumab

CAS: 1353485-38-7

Anti-Human B7-H3 Monoclonal Antibody

Ref: 3D-CLA1041